Mealtime Blood Glucose Classifier Based on Fuzzy Logic for the DIABTel Telemedicine System
AIME '09 Proceedings of the 12th Conference on Artificial Intelligence in Medicine: Artificial Intelligence in Medicine
IEEE Transactions on Information Technology in Biomedicine - Special section on new and emerging technologies in bioinformatics and bioengineering
International Journal of Telemedicine and Applications - Special issue on healthcare applications and services in converged networking environments
Computer Methods and Programs in Biomedicine
ICCSA'12 Proceedings of the 12th international conference on Computational Science and Its Applications - Volume Part III
Smart wearable systems: Current status and future challenges
Artificial Intelligence in Medicine
A generic telemedicine infrastructure for monitoring an artificial pancreas trial
Computer Methods and Programs in Biomedicine
Hi-index | 0.00 |
Biomedical engineering research efforts have accomplished another level of a ldquotechnological solutionrdquo for diabetes: an artificial pancreas to be used by patients and supervised by healthcare professionals at any time and place. Reliability of continuous glucose monitoring, availability of real-time programmable insulin pumps, and validation of safe and efficient control algorithms are critical components for achieving that goal. Nevertheless, the development and integration of these new technologies within a telemedicine system can be the basis of a future artificial pancreas. This paper introduces the concept, design, and evaluation of the ldquointelligent control assistant for diabetes, INCArdquo system. INCA is a personal digital assistant (PDA)-based personal smart assistant to provide patients with closed-loop control strategies (personal and remote loop), based on a real-time continuous glucose sensor (Guardian RT, Medtronic), an insulin pump (D-TRON, Disetronic Medical Systems), and a mobile general packet radio service (GPRS)-based telemedicine communication system. Patient therapeutic decision making is supervised by doctors through a multiaccess telemedicine central server that provides to diabetics and doctors a Web-based access to continuous glucose monitoring and insulin infusion data. The INCA system has been technically and clinically evaluated in two randomized and crossover clinical trials showing an improvement on glycaemic control of diabetic patients.